chrisvoncsefalvay/vaers-outcomes huggingface dataset:
facial flushing; did not feel great; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (facial flushing) and MALAISE (did not feel great) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was provided.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced FLUSHING (facial flushing) and MALAISE (did not feel great). At the time of the report, FLUSHING (facial flushing) and MALAISE (did not feel great) outcome was unknown.            No treatment information was provided
Chest pain, hypotension, pre-syncope, elevated D dimer, and crp. Myalgia, headache, fever, joint pain, abdominal pain starting around 1030 am the following day. These severe symptoms lasted about 36 hours. Then continued with abdominal/pelvic pain and resulting in an interstitial cystitis symptomatology. This lasted an additional 2 weeks with increased fatigue.
HYPOXIA 12/8/2022 ESOPHAGEAL CANCER, UNSPECIFIED SITE HYPOXIA 12/8/2022 ALZHEIMERS DISEASE
Erythema and puffiness around injection site.  Two pox lesions on lower trunk.
major flu-like symptoms; myalgia; fatigue; headache; shivering; fever; gastrointestinal symptoms; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2019, the patient received Shingrix (intramuscular). In May 2019, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms, myalgia, fatigue, headache, shivering, fever and gastrointestinal symptom nos. On an unknown date, the outcome of the influenza-like symptoms, myalgia, fatigue, headache, shivering, fever and gastrointestinal symptom nos were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, myalgia, fatigue, headache, shivering, fever and gastrointestinal symptom nos to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 1st shot of Shingrix and the next 48 hours he had major flu-like symptoms, he had to take the next day off work.  The patient experienced myalgia , fatigue, headache, shivering, fever, and gastrointestinal symptoms.  All event resolved after 3 days. The reporter did not consent to follow up.
This case was reported by a nurse and described the occurrence of inappropriate age at vaccine administration in a 34-month-old patient who received FLUARIX QUADRIVALENT. In December 2014, the patient received FLUARIX QUADRIVALENT .5 ml. On an unknown date, an unknown time after receiving FLUARIX QUADRIVALENT, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.
pt passed out while driving 25min p/vax;pt also taking larium, hit guardrail-to ER for tx;stated was told BP was low & EKG abn;
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: "marbled skin" appearance-Medium
After receiving Hepatitis A vaccine client became lightheaded, fainted, & vomited.  Was immediately placed in supine position.  Was nonresponsive for approximately 10 seconds. Examined by PA.  Resp 22. Pulse 100. BP 110/50. Parents present. Cold cloth to forehead. Client had not eaten yet today. Was kept in clinic under observation for 40 mintues. Fed something. Released to parents.
Pt was supposed to get 2nd dose of Moderna. Pt was administered 0.25ml. Pt was offered another 0.25ml to complete the series.  Pt refused. Said she would go to another pharmacy.
This spontaneous report received from a nurse referred to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 08-AUG-2017, the patient was vaccinated with improperly stored M-M-R II (lot M042846; expiry date: 21-OCT-2018) reconstituted with properly stored sterile diluent and VAQTA (lot N005274; expiry date: 03-APR-2018). The vaccines were exposed to temperature range of 9°C to 25°C for 16 minutes. There was no previous temperature excursion. The call was because of a data logger. No adverse effects reported. This is one of the two reports received from the same reporter. Sender's Comments: US-009507513-1708USA004578.
Patient arrived at Covid Vaccine Clinic for his 2nd dose of Covid Vaccine.  It was discovered upon arrival that he was 17 and was presenting for his 2nd dose of Moderna.  Chart review revealed he had received Moderna dose 1 on 3/10/21.  Patient reported no issues with Moderna dose 1 and stated understanding of why we were reviewing appropriateness of dose 2 for him.  Discussed case with Dr.  Dr  supported patient receiving dose 2 of Moderna and cited the CDC reference ?If age 16 to 17 years and a vaccine other than Pfizer-BioNTech was inadvertently administered: If Moderna vaccine administered as the first dose, may administer Moderna vaccine as the second dose (as off-label use, because Moderna vaccine is not authorized in this age group0
Sciatica and hypertensive encephalopathy readmitted 1 day after vaccination
49yo M patient with no PMH, here to receive the Pfizer COVID vaccine booster. Approx. 10min after receiving the vaccine he felt "Dizzy". Patient admitted that he had just a small breakfast early this morning and that this has happened before when he is fasting. Claims that everything went well with the previous 2 vaccine doses. Denies any other symptom. Patient was evaluated by on-site EMS and MD. On physical exam noted to be AAO x 3; Initial VS: HR 76, RR 20, SpO2 98%, BP 120/86, capillary blood glucose: 82. Heart with RRR, lungs clear bilaterally. Patient was offered apple juice, he drank 12oz. After 15min observation patient felt better. He was discharged home with complete resolution of symptoms.
Started with chills, fever.  Next morning could hardly get out of bed. Very weak and throwing up black liquid. Could not take care of self for 2 and one-half days.  Very weak for 4 days.  I was sick with the 1st vaccine for a day one-half with chills and fever  but nothing compared to the 2nd one.  I will not taken another Pfizer vaccine ever.
severe fatigue 5 hours, moderate headache 5 hours, mild nausea 5 hours and moderate chills for 5 hours
The patient got 2 doses of Moderna vaccine this morning within a matter of minutes; This spontaneous case was reported by a nurse and describes the occurrence of EXTRA DOSE ADMINISTERED (The patient got 2 doses of Moderna vaccine this morning within a matter of minutes) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Sep-2021, the patient experienced EXTRA DOSE ADMINISTERED (The patient got 2 doses of Moderna vaccine this morning within a matter of minutes). At the time of the report, EXTRA DOSE ADMINISTERED (The patient got 2 doses of Moderna vaccine this morning within a matter of minutes) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
On day 8th started with a hot red swollen raised large rash on my left arm at the injection site. I also had sore arm fatigue, and headache. Doctor diagnosed it as cellulitis and given an antibiotic.
This spontaneous report was received from a licensed practical nurse concerning a female patient of unknown age. The medical history of the patient included allergic reaction described as a rash to penicillin on an unspecified date. On 25-JUN-2013, the patient was vaccinated with a dose of PROQUAD (Merck) (lot number and expiry date reported as H020852 and 26-MAY-2014 respectively, dose unspecified), subcutaneously instead of M-M-R II. The patient was also vaccinated with a dose of VARIVAX (Merck) (lot number, expiry date, dose and route unspecified) concomitantly on 25-JUN-2013. No adverse effects were reported. Additional information has been requested.
Coughing,  sneezing , out of breath, rash from waist down, itchy and painful ,  toes red and swolen .
Patient called Monday to report that since she had the shot on Friday, she cannot move arm without severe arm pain and cannot lift arm due to pain.  She also stated she had temperature 102 degrees F.  She could not go to doctor, so I called her back on Wednesday to check her condition.  She said she had minimal improvement.  I suggested she at least call her doctor to report it, in case it got worse.  She said she would consider it.    I am unaware of the final outcome of her condition.
patient had pain in the left arm that radiated thru her should blades and down her right arm.  intermittent numbness in the arms.
Patient became flushed, diaphoretic, N/V. vitals taken Pt. taken to private area, given juice and crackers and continued to be monitored by EMT.  Released at 16:08 P.M. Seen by EMT onsite. RN recorded.
Patient is a 79-year-old male with history of right lung mass and recent Multiple rib fractures on the left after a fall presenting to the emergency department via EMS for respiratory distress. Patient was discharged from hospital earlier today.  He did get home via EMS, and his caregiver was home when he arrived. She states she helped him to his hospital bed that she was able to obtain, and the home health nurse also came to see how he was doing.  She states about an hour or 2 after he got home, he became unresponsive, so she quickly called 911. Upon arrival to the ED, patient has decreased responsiveness, he was placed on a CPAP by EMS, however continued to be hypoxic in the 80s. EMS did give a total of 2 g of Narcan IV which helped patient awake some, however did not resolve the symptoms. Caregiver at bedside states she did not give him any medications once he came home today.
Seriousness criteria Other medically significant. Initial report received from physician on 25 May 2006. A 35 year old pregnant female received the injection of Adacel on 11 Mar 2006. Lot number, route and site of administration was not reported. The patient received the immunization due to having young children at home. The patient has had three full term, viable pregnancies. Last menstrual period was 02 Mar 2006 with expected date of delivery 07 Dec 2006. Per reporter, no adverse event was reported. Follow up information received on 14 Aug 2006 from a health care professional. Adacel, lot number C2384AA, was administered in the left arm. The patient has no past medical problems, but is 35 years old (advanced maternal age). Estimated date of delivery is provided as 06 Dec 2006. Ultrasound, performed on 20 Jul 2006, and nuchal translucency testing, performed on 31 May 2006 were normal. Per the reporter, the patient had not experienced any adverse event. Follow up information received on 25 January 2007. The complete pregnancy report form was received. The patient also received flu vaccine (lot number 69690) on 19 October 2006. she was on prenatal vitamins (for pregnancy, 1/d po) since 1st trimester and insulin (A2 diabetes, 30 UNPH qd) thru 3rd trimester only. The patient did not experience an adverse event. Her current pregnancy history was documented as only advanced maternal age and gestational diabetes. Her pregnancy complication was reported as gestational diabetes. She had an alpha feto protein on 23 June 2006 serologies on 10 May 2006, several fetal non stress tests, several ultrasounds, 1st trimester nuchal screen-all had normal results. There were no complications of labor and/or delivery. The patient gave birth vaginally on 30 November 2006, at 39 gestational weeks, to one male, live child (with no congenial anomaly) who weight 6 lbs 7 oz. A corrective version was created on 05 February 2007 with a latest received date of the previous version (25 January 2007) in order to upgrade the case to serious as based upon the medical information provided on 25 January 2007 (report of gestational diabetes).
Janssen 3/24/21. Moderna 1/5/22. Positive on 6/6/22
Information has been received from a Allergy Technician concerning a 14 year old female patient with no pertinent medical history and no drug reactions or allergies who on 14-NOV-2008 was vaccinated with a first dose of GARDASIL (Lot # 656049/0187U) 0.5ml, intramuscularly. Concomitant therapy included influenza virus vaccine (unspecified). On approximately 05-DEC-2008 the patient experienced fatigue and headaches. The patient was a basketball player and she could not participate in some recent drills. The patient had a schedule appointment to see a cardiologist on 06-MAY-2009. On 09-JAN-2009 the following diagnostics laboratory test were performed: Completed blood cell count (CBC), blood hemoglobin test (HGB): 11.7 was low, Lymphatic percentage: 47.2 was high and lymphatic number: 3.2 was high. At the time on the report on 17-APR-2009 the patient had not recovered. The patient sought medical attention was at office. Additional information has been requested.
Date of Service: 3/31/12. Two days after received PVC13 on the right thigh. Did not notice any redness or swelling until this AM. No pain. Itches a little. No fever. NO drainage. Ambulating well. Patient was Rx BACTRIM PO susp. 200mg 40/5ml. BENADRYL BID as needed. Motrin/Tylenol for pain.
Severe headache and nausea after COVID booster, continued and required ER visit 12/22/2022.
Vomited the evening after getting the vaccine.   Has had daily diarrhea since vaccine. Watery stools dailyl. No normal stools since  Pt is insulin dependent diabetic, having hypoglycemic episodes.   CBG has been as low as 43, needed glucose   She has also had an increase in tics   Neck pain  Neck tic, urge to turn neck to the side  Eye blinking tic
Excruciating pain - abduction extremely painful - seen a doctor 8/31 - neuropathic pain - know that she hit nerve - but not sure how much damage.
mom states pt began crying about 11AM & cried until 3PM; @ which time they went for a ride in the car; when got home 4PM & got out of the car pt began crying again; had high pitched cry; would not take formula only juice;
Donor experienced sudden onset nausea/vomiting and diarrhea approx 20 minutes after vaccination.
Covid vaccine dose #4 given in error (pt was suppose to get flu shot + 1 covid 3rd dose), pt instead received 2 covid 19 vaccine and once rph realized error, pt received flu shot.  Error occurred due to distraction and talking to patient. Rph followed up with patient next day and husband stated pt had some shortness of breath earlier but no problems (24 h later)
Grabbing things to steady herself; Lightheadness; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Grabbing things to steady herself), DIZZINESS (Lightheadness) and DIZZINESS (Dizziness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced GAIT DISTURBANCE (Grabbing things to steady herself), DIZZINESS (Lightheadness) and DIZZINESS (Dizziness). At the time of the report, GAIT DISTURBANCE (Grabbing things to steady herself), DIZZINESS (Lightheadness) and DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were reported. No Treatment Medications were reported.
nausea, dry heaves, diarrhea. Probably fever (but too sick to get up to take temperature). No treatment.  Totally resolved by 5:30am on 5/20.
Shingles outbreak on left side of face. Treated with oral Valtrex x 10 days.  Scar still present on the face
Initially pain on right lower abdomen and back, then rash developed in linear band across abdomen and one spot on back. Bumps clustered, although did not blister. Began scabbing 4-5 days after onset. Itching began after 1.5 weeks. Pain subsided following full course of valacyclovir after diagnosis with shingles. Had chickenpox sometime between ages 3-6.
Patient came in to pharmacy concerned about symptoms of fatigue, lack of appetite, and joint pain (back pain). She received a Prevnar 13 vaccine on 4/6/2016.  She stated the symptoms began last week (today is 4/21/16), and the symptoms have gotten progressively worse.  She believes the symptoms could possibly be due to the vaccine.  I recommended she consult with her primary care physician to rule out other possible causes.
pt rt thigh is swollen, red, erythematous sl raised rash about 3x3 1/2 all around the area of site of inj;tender & warm;no other areas affected;
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. The patients' medical histories, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients received an improperly stored dose of PROQUAD (lot# M015695, expiration date 26-SEP-2017, recombinant human albumin (rHA); lot# L051098, expiration date 17-JUN-2017, rHA; lot# M006102, expiration date 01-AUG-2017, rHA, dose and route were unknown). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt's wife reports "he had a fever and swollen lymph nodes in his jaw and elbow.  the injection site arm was tender to touch"
This case was reported by a contact and descried the occurrence of swelling arm in a adult female patient who received Influenza vaccine. Previously administered products included flu vaccine. On 21st October 2014, the patient received Influenza vaccine. On an unknown date, less than a day after receiving Influenza vaccine, the patient experienced swelling arm, head pressure and painful arm. The patient was treated with BENADRYL. On an unknown date, the outcome of the swelling arm, head pressure and painful arm were unknown. It was unknown if the reporter considered the swelling arm, head pressure and painful arm to be related to Influenza vaccine.
Profound fatigue, muscle aches and pains throughout body, joint aches, headaches, brain fog, lymph node swelling throughout body, insomnia, depression
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore arm). At the time of the report, MYALGIA (sore arm) outcome was unknown.            Relevant concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-312975, MOD-2021-313035 (Patient Link).
Generalized itching and tingling, started 2 days after GARDASIL vaccine was given. At first diffuse, then over a few days was localized to patches on the back and abdomen.
Muscle pain; Shortness of breath; Tiredness; Nausea; Sweating; Mild soreness at infection site; Mild soreness at infection site; This is a Spontaneous report from a contactable Other HCP (patient). A 51-year-old female patient (no pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (lot number=EH9899), on 30Dec2020 12:00 PM, Intramuscularly at single dose (first dose), (vaccine location=Left arm) for COVID-19 immunization. Medical history included Covid; Hypertension; Diabetes Type 2. Concomitant medications were not reported. Patient was no Known allergies. Patient experienced Muscle pain, shortness of breath, tiredness, nausea, sweating, mild soreness at infection site on 02Jan2021 09:00 AM. Patient did not receive any treatment. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient did not have been tested for COVID-19. The outcome of the events was not recovered. This case was assessed non-serious by reporter. And the events did not result in Death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect.
ADMINISTRATION OF VACCINE THAT WAS LEFT OUT OF FRIDGE FOR FOUR AND A HALF HOURS; This spontaneous report received from a pharmacist concerned an 18 year old male. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry: 23-JUN-2021) dose was not reported, administered on 08-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-MAY-2021, the subject experienced administration of vaccine that was left out of fridge for four and a half hours. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of vaccine that was left out of fridge for four and a half hours was not reported. This report was non-serious.
the patient was treated by a healthcare provider for shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender.   The patient's current conditions, medical history and concomitant medications were not reported.   In 2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (route, dosage information and lot number were unknown) for long-term prevention of shingles and/or zoster-related conditions.  On an unknown date the patient experienced herpes zoster and was hospitalized.       It was also mentioned that as a direct and proximate result of Patient's use of the zoster vaccine live (ZOSTAVAX), the Patient had and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.  The outcome of herpes zoster was reported as not recovered.  The reporter considered herpes zoster to be related to Zoster Vaccine Live(ZOSTAVAX).